週次 |
日期 |
單元主題 |
第1週 |
Sep. 5 |
Introduction to the immune system
Course introduction
Innate immunity (Ch. 1, 2) |
第2週 |
Sep. 12 |
Innate immunity
Components of the immune system (Ch. 1)
Cytokines and Chemokines (Ch. 1, 3, 8)
Antibody structure and diversity
Antibody structure and the generation of B cell diversity (Ch. 5)
|
第3週 |
Sep. 19 |
The recognition of antigen (TCR, BCR, MHCI, MHCII)
Antigen recognition by B-cell and T-cell receptors (Ch. 6)
Antigen presenting cells (Ch. 6)
Integrated dynamics of innate and adaptive immunity (Ch. 6)
|
第4週 |
Sep. 26 |
The Development of B Lymphocyte
Major lymphoid organs and tissues (Ch. 9)
B cell maturation (Ch. 9)
Monoclonal antibody production and purification
|
第5週 |
Oct. 3 |
The Development of T Lymphocytes
TCR α and β chain gene recombination and expression (Ch. 8)
Three kinds of signals are involved in activation of naïve T cells by antigen-presenting cells (Ch. 8)
Immunity Mediated by B Cells and Antibodies
Affinity maturation
Classify antibodies into five types
|
第6週 |
Oct. 10 |
National Holiday |
第7週 |
Oct. 17 |
Monoclonal antibodies and their applications
Therapeutic antibodies: structure and function
Generation of monoclonal antibody: hybridoma, phage display, and single B cell
Monoclonal antibodies and their applications
|
第8週 |
Oct. 24 |
期中考 Midterm |
第9週 |
Oct. 31 |
【Antibody-related techniques I】In Mandarin and English
Instructions for writing your laboratory notebook
Experimental design and the interpretation of data
Histologic specimen stained with hematoxylin and eosin
How to pick up a good antibody for your experiment?
【Antibody-related techniques II】In Mandarin and English
Immunohistochemistry (IHC)
Immunofluorescence (IF)
|
第10週 |
Nov. 7 |
Immunotherapy and CAR-T Therapy, Part 1
Neoantigen
Neoantigen prediction
Cancer treatments
Immunotherapy I
|
第11週 |
Nov. 14 |
Immunotherapy and CAR-T Therapy, Part 2
Immunotherapy II
Immunomodulators
Monoclonal Antibodies, Antibody-Drug Conjugates, and Bispecific Antibodies
|
第12週 |
Nov. 21 |
Immunotherapy and CAR-T Therapy, Part 3 Adoptive Cell Therapy
Engineered T cell
Tumor-Infiltrating Lymphocyte (TIL) Therapy
Chimeric Antigen Receptor (CAR) T Cell Therapy
|
第13週 |
Nov. 28 |
Cancer Immune Escape and Tumor Microenvironment
Immunosurveillance
Cancer immune escape
Tumor Microenvironment (TME)
|
第14週 |
Dec. 5 |
期末報告 Final Presentation I |
第15週 |
Dec. 12 |
期末報告 Final Presentation I |
第16週 |
Dec. 19 |
期末報告 Final Presentation I |